We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
What's in Store for Barings BDC (BBDC) This Earnings Season?
Read MoreHide Full Article
Barings BDC, Inc. (BBDC - Free Report) is slated to announce third-quarter 2020 results on Nov 11, after market close. Its earnings for the to-be-reported quarter are expected to have declined year over year.
In the last reported quarter, the company’s earnings lagged the Zacks Consensus Estimate. Results were affected a fall in investment income, partly offset by lower expenses.
Barings BDC has an unimpressive earnings surprise history. Its earnings lagged the Zacks Consensus Estimate in three of the trailing four quarters, the negative surprise being 4.79%, on average.
Before we take a look at what our quantitative model predicts for the third quarter, let’s check the factors that are likely to have influenced its performance.
Factors at Play
Given the low interest rates environment during the third quarter, interest income from investment, and other income are likely to have been negatively impacted. Also, slowdown in the middle market lending due to the pandemic is expected to have kept net investment income under pressure during the third quarter.
On the cost front, Barings BDC has been witnessing lower expenses over the past several quarters. Moreover, as the company continues to make efforts at costs savings, operating expenses are likely to have been low in the to-be-reported quarter.
What the Zacks Model Unveils
Our proven model does not conclusively predict an earnings beat for Barings BDC this season. This is because it doesn’t have the right combination of the two key ingredients — a positive Earnings ESP and Zacks Rank #3 (Hold) or better — to increase the odds of an earnings beat.
You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Earnings ESP: Barings BDC has an Earnings ESP of -1.64%.
Zacks Rank: The company currently carries a Zacks Rank #3.
Notably, activities of the company in the third quarter were inadequate to win analysts’ confidence. As a result, the Zacks Consensus Estimate for earnings of 15 cents remained unchanged over the past seven days. It indicates a fall of 6.3% from the year-ago reported number.
However, the Zacks Consensus Estimate for sales is pegged at $16.9 million, which reflects 12.6% growth.
Earnings Dates of Other Finance Stocks
Among other finance stocks, Golub Capital BDC, Inc. (GBDC - Free Report) and Gladstone Capital Corporation (GLAD - Free Report) are scheduled to release results on Nov 23 and Nov 11, respectively. Oaktree Strategic Income Corp. will report on Nov 19.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
What's in Store for Barings BDC (BBDC) This Earnings Season?
Barings BDC, Inc. (BBDC - Free Report) is slated to announce third-quarter 2020 results on Nov 11, after market close. Its earnings for the to-be-reported quarter are expected to have declined year over year.
In the last reported quarter, the company’s earnings lagged the Zacks Consensus Estimate. Results were affected a fall in investment income, partly offset by lower expenses.
Barings BDC has an unimpressive earnings surprise history. Its earnings lagged the Zacks Consensus Estimate in three of the trailing four quarters, the negative surprise being 4.79%, on average.
BARINGS BDC, INC. Price and EPS Surprise
BARINGS BDC, INC. price-eps-surprise | BARINGS BDC, INC. Quote
Before we take a look at what our quantitative model predicts for the third quarter, let’s check the factors that are likely to have influenced its performance.
Factors at Play
Given the low interest rates environment during the third quarter, interest income from investment, and other income are likely to have been negatively impacted. Also, slowdown in the middle market lending due to the pandemic is expected to have kept net investment income under pressure during the third quarter.
On the cost front, Barings BDC has been witnessing lower expenses over the past several quarters. Moreover, as the company continues to make efforts at costs savings, operating expenses are likely to have been low in the to-be-reported quarter.
What the Zacks Model Unveils
Our proven model does not conclusively predict an earnings beat for Barings BDC this season. This is because it doesn’t have the right combination of the two key ingredients — a positive Earnings ESP and Zacks Rank #3 (Hold) or better — to increase the odds of an earnings beat.
You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Earnings ESP: Barings BDC has an Earnings ESP of -1.64%.
Zacks Rank: The company currently carries a Zacks Rank #3.
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Notably, activities of the company in the third quarter were inadequate to win analysts’ confidence. As a result, the Zacks Consensus Estimate for earnings of 15 cents remained unchanged over the past seven days. It indicates a fall of 6.3% from the year-ago reported number.
However, the Zacks Consensus Estimate for sales is pegged at $16.9 million, which reflects 12.6% growth.
Earnings Dates of Other Finance Stocks
Among other finance stocks, Golub Capital BDC, Inc. (GBDC - Free Report) and Gladstone Capital Corporation (GLAD - Free Report) are scheduled to release results on Nov 23 and Nov 11, respectively. Oaktree Strategic Income Corp. will report on Nov 19.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>